Blood test may predict success of liver surgery for rare eye cancer
NCT ID NCT02849145
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 36 times
Summary
This study looked at whether measuring tumor DNA in the blood can help doctors understand how well surgery worked for uveal melanoma that spread to the liver. About 60 adults with this condition had blood samples taken before and after surgery. The goal was to see if changes in tumor DNA levels could predict if all cancer was removed and if it would come back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Curie
Paris, 75005, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.